VACCINEX, INC.

Profile

Company Names

VACCINEX, INC.

Addresses

1895 MOUNT HOPE AVE, ROCHESTER, NY 14620

1895 MOUNT HOPE AVENUE, ROCHESTER, NY 14620

Phone Numbers

585-271-2700

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$44,465,793.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-09-18 
$200,155.00 
$9,224,732.00 
$9,024,577.00 
 
8
2024-03-29 
$1,750,000.00 
$3,499,995.00 
$1,749,995.00 
Equity 
7
2024-03-28 
$1,240,737.00 
$2,462,090.00 
$1,221,353.00 
Equity 
6
2020-09-01 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
5
2020-08-03 
$8,000,000.00 
$8,000,000.00 
$0.00 
Debt 
4
2020-07-10 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
3
2020-01-23 
$7,474,986.00 
$7,474,986.00 
$0.00 
Equity 
2
2019-07-30 
$13,799,915.00 
$13,799,915.00 
$0.00 
Equity 
1
2017-05-31 
$6,000,000.00 
$18,200,000.00 
$12,200,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRYSTYNA 
 
BEDRIJ STECYK 
DIRECTOR
VACCINEX, INC.
ALEJANDRO 
M. 
BERLIN 
DIRECTOR
VACCINEX, INC.
STEVEN 
P. 
COBOURN 
EXECUTIVE OFFICER
VACCINEX, INC.   |  NEXTCURE, INC.
ALAN 
L. 
CRANE 
DIRECTOR
CERULEAN PHARMA INC.   |  VACCINEX, INC.   |  KSQ THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC
ELIZABETH 
 
EVANS 
EXECUTIVE OFFICER
VACCINEX, INC.
JACOB 
B. 
FRIEBERG 
DIRECTOR
VACCINEX, INC.
ALBERT 
D. 
FRIEDBERG 
DIRECTOR
VACCINEX, INC.
J. 
JEFFREY 
GOATER 
DIRECTOR
VACCINEX, INC.
J. JEFFREY 
 
GOATER 
DIRECTOR
VACCINEX, INC.
JOHN 
E. 
LEONARD 
EXECUTIVE OFFICER
VACCINEX, INC.
BALA 
S. 
MANIAN 
DIRECTOR
VACCINEX, INC.
BALA 
S. 
MANIAN PH.D. 
DIRECTOR
VACCINEX, INC.
BALA 
S. 
MANIAN, PH.D. 
DIRECTOR
VACCINEX, INC.
SCOTT 
E. 
ROYER 
EXECUTIVE OFFICER
VACCINEX, INC.
JILL 
 
SANCHEZ 
EXECUTIVE OFFICER
VACCINEX, INC.
ERNEST 
S. 
SMITH 
EXECUTIVE OFFICER
VACCINEX, INC.
ERNEST 
S. 
SMITH PH.D. 
EXECUTIVE OFFICER
VACCINEX, INC.
ERNEST 
S. 
SMITH, PH.D. 
EXECUTIVE OFFICER
VACCINEX, INC.
GERALD 
E. 
VAN STRYDONCK 
DIRECTOR
VACCINEX, INC.
RAYMOND 
E. 
WATKINS 
EXECUTIVE OFFICER
VACCINEX, INC.
BARBARA 
 
YANNI 
DIRECTOR
SYMIC HOLDINGS, LLC   |  VACCINEX, INC.   |  MESENTECH INC.
BARBARA 
 
YANNNI 
DIRECTOR
VACCINEX, INC.
MAURICE 
 
ZAUDERER 
EXECUTIVE OFFICER, DIRECTOR
VACCINEX, INC.
MAURICE 
 
ZAUDERER, PH.D. 
DIRECTOR, EXECUTIVE OFFICER
VACCINEX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-09-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2024-09-18 
2024-04-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2024-03-28 
2024-04-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2024-03-28 
2024-04-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2024-03-29 
2020-09-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2020-09-01 
2020-08-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Debt 
2020-08-03 
2020-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2020-07-10 
2020-02-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2020-01-23 
2019-08-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2019-07-30 
2017-07-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361